Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation.
Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation. Clin Transplant. 2003 Aug; 17(4):369-76.